Updates are available Correction dated 2020-02-26
Click to view Correction: https://doi.org/10.1186/s13058-020-01259-w
-
Authors
Mavaddat, Nasim http://orcid.org/0000-0003-0307-055X
,
Antoniou, Antonis C.
Mooij, Thea M.
Hooning, Maartje J.
Heemskerk-Gerritsen, Bernadette A.
Noguès, Catherine
Gauthier-Villars, Marion
Caron, Olivier
Gesta, Paul
Pujol, Pascal
Lortholary, Alain
Barrowdale, Daniel
Frost, Debra
Evans, D. Gareth
Izatt, Louise
Adlard, Julian
Eeles, Ros
Brewer, Carole
Tischkowitz, Marc
Henderson, Alex
Cook, Jackie
Eccles, Diana
van Engelen, Klaartje
Mourits, Marian J. E.
Ausems, Margreet G. E. M.
Koppert, Linetta B.
Hopper, John L.
John, Esther M.
Chung, Wendy K.
Andrulis, Irene L.
Daly, Mary B.
Buys, Saundra S.
Benitez, Javier
Caldes, Trinidad
Jakubowska, Anna
Simard, Jacques
Singer, Christian F.
Tan, Yen
Olah, Edith
Navratilova, Marie
Foretova, Lenka
Gerdes, Anne-Marie
Roos-Blom, Marie-José
Van Leeuwen, Flora E.
Arver, Brita
Olsson, Håkan
Schmutzler, Rita K.
Engel, Christoph
Kast, Karin
Phillips, Kelly-Anne
Terry, Mary Beth
Milne, Roger L.
Goldgar, David E.
Rookus, Matti A.
Andrieu, Nadine
Easton, Douglas F.
,
,
,
,
,
,
-
Funding
Funding for this research was provided by:
Cancer Research UK (C1287/A17523, C1287/23382, C1287/A16563, C12292/A20861, C12292/A11174)
National Cancer Institute (UM1 CA164920)
German Cancer Aid (grant no 110837)
European program ERA-NET on Translational Cancer Research (TRANSCAN-JTC2012, n°2014-008)
Dutch Cancer Society (NKI1998-1854, NKI2007-3756)
Dutch Cancer Society (NKI2004-3088)
Genome Canada and the Canadian Institutes of Health Research (GPH-129344)
- License Information
-
More Information
Article History
Received: 7 June 2019
Accepted: 5 January 2020
First Online: 16 January 2020
Change Date: 26 February 2020
Change Type: Correction
Change Details: After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.
Ethics approval and consent to participate
: Participants provided written informed consent, and studies were approved by a relevant ethics committee.
: Not applicable
: Wendy Chung reports potential conflict of interest from Regeneron and Biogen; Olivier Caron from AstraZeneca and IPSEN; Pascal Pujol, AstraZeneca, Genomic Health and Roche; D Gareth Evans, AstraZeneca and AmGen; Ros Eeles, Janssen-Cilag; Diane Eccles, Pierre Fabre, AstraZeneca; Karin Kast, Roche Pharma AG; and David Goldgar, University of Utah Foundation and Ambry Genetics. Anne-Marie Gerdes participated in an Advisory Board Meeting London in 2016, sponsored by Astra Zeneca about BRCA-testing in ovarian cancer.
